Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Which is the Best IVF/ICSI Protocol to be Used in Poor Responders Receiving Growth Hormone as an Adjuvant Treatment ? A Prospective Randomized Study

NCT01897324 is registered in ClinicalTrials.gov with Woman's Health University Hospital, Egypt as lead sponsor.

NCT NCT01897324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01897324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Which is the Best IVF/ICSI Protocol to be Used in Poor Responders Receiving Growth Hormone as an Adjuvant Treatment ? A Prospective Randomized Study
Lead sponsor
Woman's Health University Hospital, Egypt
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2013
Completion date
January 31, 2015
Enrollment
287 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female infertility due to diminished ovarian reserve